Keyphrases
Randomized Controlled Trial
100%
Difficile
100%
Clostridioides Difficile
100%
Oral Vancomycin
100%
Clostridium Difficile Infection
75%
Vancomycin
50%
Placebo
37%
Multidrug-resistant Organisms
37%
Vancomycin-resistant Enterococci
37%
Nucleic Acid Amplification Test
37%
Environmental Contamination
37%
Fecal Samples
25%
Potential Gains
12%
Adverse Outcomes
12%
Positive Predictive Value
12%
Microbiome
12%
Antibiotics
12%
Decreased Risk
12%
Gut Microbiota
12%
Antibiotic Treatment
12%
Risk-benefit
12%
Intestinal Microbiota
12%
Existing Data
12%
Low Positive
12%
Infection Treatment
12%
Microbiota
12%
Macrolides
12%
Toxin Immunoassays
12%
Resistance Genes
12%
Environmental Samples
12%
Shotgun Proteomics
12%
Beta Diversity
12%
Stool Test
12%
Streptogramins
12%
Lincosamides
12%
Medicine and Dentistry
Randomized Controlled Trial
100%
Vancomycin
100%
Infection
50%
Placebo
30%
Vancomycin Resistant Enterococcus
30%
Nucleic Acid Amplification
30%
Diagnosis
10%
Adverse Outcome
10%
Antibiotic Therapy
10%
Gut Microbiota
10%
Microbiome
10%
Macrolide
10%
Infectious Disease Treatment
10%
Enzyme Immunoassay
10%
Streptogramin
10%
Lincosamide
10%
Stool Test
10%
Antibiotics
10%
Immunology and Microbiology
Vancomycin-Resistant Enterococcus
100%
Nucleic Acid Amplification
100%
Intestine Flora
66%
Metagenomics
33%
Microflora
33%
Enzyme Immunoassay
33%
Microbiome
33%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Vancomycin
100%
Vancomycin Resistant Enterococcus
30%
Nucleic Acid Amplification
30%
Enzyme
20%
Intestine Flora
20%
Immunoassay
10%
Metagenomics
10%
Microflora
10%
Microbiome
10%
Macrolide
10%
Genomics
10%